GenSigt will participate to the Ophthalmology Innovation Summit at the Hilton San Francisco Union Square  on October 10, 2019 on the occasion of the American Academy of Ophthalmology, October 12-15, 2019.

Thomas Gidoin, Chief Financial Officer, will present the Clinical Results from REVERSE & RESCUE Phase III Clinical Trials of GS010 for Treatment of Leber Hereditary Optic Neuropathy (LHON).

  • Session title: Speciality Showcase Sessions – Gene & Cell Therapy Spotlight
  • Time:  3:40 PM